טוען...
Prolonged survival after multimodal therapy for pleural mesothelioma: Don't give up the follow-up. A case report
Malignant Pleural mesothelioma (MPM) is a rare disease which is associated with a poor prognosis. Front line chemotherapy represents the cornerstone in the management of MPM, and the place of radical surgery is controversial and reserve in early-stage disease. However prolonged survival (more than 2...
שמור ב:
| הוצא לאור ב: | Ann Med Surg (Lond) |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683176/ https://ncbi.nlm.nih.gov/pubmed/33251003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.11.034 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|